Table 2.
Variable | N suicide | Unadjusted SHR (95% CI) | P value | Adjusted SHR (95% CI)a | P value |
---|---|---|---|---|---|
Early discontinuationb | 12 | 0.74 (0.42–1.32) | 0.31 | 0.82 (0.46–1.42) | 0.50 |
Combination use of ≥ 2 antidepressantsc | 16 | 2.31 (1.39–3.84) | 0.001 | 1.28 (0.74–2.22) | 0.38 |
Switch to another antidepressantd | 35 | 3.37 (2.35–4.82) | < 0.001 | 2.42 (1.65–3.55) | < 0.001 |
Medication possession ratio of antidepressants < 80%e | 85 | 1.24 (0.97–1.58) | 0.08 | 1.02 (0.79–1.10) | 0.89 |
Concomitant use of psychotropic medicationsf | 241 | ||||
Hypnotics | 207 | 2.57 (1.99–3.30) | < 0.001 | 2.20 (1.69–2.85) | < 0.001 |
Anxiolytics | 154 | 2.18 (1.72–2.77) | < 0.001 | 1.54 (1.20–1.96) | < 0.001 |
Antipsychotics | 39 | 1.38 (1.98–1.93) | 0.06 | 1.73 (1.19–2.51) | 0.004 |
Anti-dementia drugs | 14 | 0.43 (0.25–0.73) | 0.002 | 0.72 (0.42–1.24) | 0.24 |
Mood stabilisers | 5 | 0.79 (0.32–1.89) | 0.58 | 0.74 (0.30–1.79) | 0.50 |
.Due to partially missing data, 210 persons were excluded from the regression analysis
SHR sub-hazard ratio
aAdjusted for age, sex, suicide attempt within 1 year preceding the index date, serious depression, use of statins (a proxy of cardiovascular comorbidity), and nursing home residence
bReference group: those who did not discontinue their treatment within 180 days following the index date
cReference group: those who did not combine two antidepressants within 180 days following the index date
dReference group: those who did not switch to another antidepressant within 180 days following the index date
eThe proportion of days covered by antidepressant medications during the follow-up period. (Threshold of MPR to define adherence ≥ 80%)
fReference group: those who did not use the specified psychotropic medication within 90 days following the refill of an antidepressant